Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Phospholipidbound Omega3 Supplement

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT02908932Not ApplicableCompleted

Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's

Showing all 1 trials

Research Network

Common Treatments

  • Phospholipidbound Omega3 Supplement1

Active Sponsors

  • Aker BioMarine Human Ingredients AS1
  • Medical University of South Carolina1

Top Investigators

Related Conditions

  • Cognition1
  • Fatty Acids Omega31
  • Resilience Psychological1
  • Nutrition1

Activity Timeline